News About Pharmaceuticals in Mesothelioma Treatment

1. New Biomarkers May Speed Diagnosis of Mesothelioma
2. Lowered Cost of DNA Sequencing Improving Specificity of Cancer Treatment
3. Scientists Find Cell Process That Causes Mesothelioma
4. Immune Response Inhibitor Identified in Cancer Retroviruses
5. MRIs Effective in Identifying Malignant Testicular Cancer Growths
6. National Comprehensive Cancer Network Announces New Mesothelioma Guidelines
7. New Type of Cancer Vaccine May Revolutionize Treatment of Some Cancers
8. Survey Sheds Light on Severity of Breakthrough Cancer Pain
9. Mesothelioma Vaccine Proven Safe
10. Personalized Mesothelioma Vaccine Tested in Humans – article at Oncolink
11. New Treatments for Mesothelioma Show Promise
12. Cancer Scientists Isolate Fingerprint of Individual Tumors
13. High Cancer Costs Keep Patients From Seeking Treatment
14. Clinical Trials Starting Soon for Mesothelioma Drug
15. Mesothelioma Drug Phase II Trials Starting Soon in Australia
16. Targeting B-Cell Surface Proteins to Fight Cancer
17. Mesothelioma and Cancer Research – Human Epidermal Growth Factor Receptor (HER) Signaling and Cancer Therapy
18. Preparing for surgery – details to consider
19. Mesothelioma and Cancer Research – the Hedgehog signaling pathway and cancer therapy
20. Predicting the Effectiveness of Avastin
21. New Mesothelioma Detection Test Ready for Distribution
22. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
23. New Maintenance Therapy Methods for Lung Cancer
24. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
25. New Chemotherapy Combination to be tested on Mesothelioma Patients
26. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
27. Finnish Study Could Lead to Better Lung Cancer Drug
28. New Lung Cancer Drug Starts Phase II Clinical Trial
29. Gene Screening Proves Effective in Screening for Mesothelioma Survival
30. Ohio University Finds Bond between Asbestos, Human Cell Tissue – Could Lead to Understanding of Mesothelioma Pathogenesis
31. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
32. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
33. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
34. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
35. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors – Brigham and Women’s Hospital
36. Cancer Diagnosis From a Single Drop of Blood?
37. National mesothelioma virtual bank
38. Another Study Links Nanotubes To Mesothelioma
39. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
40. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
41. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
42. Research Shows Altered Immune Cells Target Mesothelin
43. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
44. Breakthrough Could Lead to New Cancer Therapies
45. Gene Fusions May Be Unique Identifier for Cancer
46. Study Examines Interactions Between Asbestos Fibers and Cells
47. Liver Tumors Treated with Chemotherapy Beads
48. Mesothelioma Researcher Receives Two Grants
49. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
50. Synthetic Material Attaches to Cells to Assist in Cancer Research
51. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
52. FDA Recommends Additional Clinical Trial for Onconase
53. ZenBio Awarded Phase II SBIR Grant for Cell Development
54. Researchers gain new insight into DNA replication
55. Study bolsters argument for treating cancer-related fatigue with exercise
56. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
57. Researchers report promising gene that causes cancer cells to self destruct
58. EPA awards $2.1 million asbestos research grant
59. Cancer research may exclude older patients
60. Vitamin supplements may not help prevent cancer
61. New treatments under development for asbestos-related cancer
62. Cancer treatment errors happen more than commonly known
63. Scientists develop nanotube technology to fight cancer cells
64. Study Shows Brief Inhibition of Cancer Cells is Effective
65. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
66. Vitamin trials for cancer prevention offer disappointing results
67. Supressing tumors in young patients may increase cancer risk in later years
68. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
69. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
70. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
71. Clinical trials struggling to attract participants
72. Study finds chemotherapy may be harmful For patients with advanced cancer
73. New cancer studies call anti-angiogenesis process into question
74. Scientists explore ways to use genes to fight cancer
75. Researchers find molecule that causes malignant cells to self-destruct
76. Research sheds light on lung cancer for non-smokers
77. Doctors look toward screening for lung cancer
78. Nanomaterial Screening helps determine which particles are toxic
79. Experts: Current pain treatment not sufficient for cancer patients
80. Massage could be beneficial for reducing cancer pain
81. New findings about chemotherapy at the molecular level
82. Transdermal patch developed for severe cancer pain
83. Too much Vitamin C may interfere with chemotherapy
84. New clues on causes of thoracic cancer
85. Telomerase gene sequence uncovered
86. Pleurodesis in the treatment and care of mesothelioma patients
87. Epigenetic drugs for cancer treatment
88. Study shows Alimta effective for maintenance therapy
89. Scientists announce advance in immunotherapy
90. Minimally invasive RFA treatment could be used for several cancer types
91. Novel strategy for cancer treatment uses patient’s own blood
92. Attacking cancer stem cells a way to treat cancer
93. Predicting cancer-fighting abilities by computer
94. Anti-inflammatory drugs investigated for chemoprevention
95. Modified chemotherapy agent improves PET scan functioning
96. Government budget cuts deter progress in fight against cancer
97. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
98. Tumor Generator Could Enhance Cancer Drug Development
99. Belgian doctors hit personalized cancer treatment milestone
100. New biomarkers for cancer developed
101. New cancer medicines track records fail to live up to hype
102. New research initiative to map genetic mutations behind cancer
103. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
104. Personalized medicine holds promise
105. Arenegyr Receives Orphan Drug Designation for Mesothelioma
106. Onconase Phase IIIb Trial Posts Mixed Results
107. Study finds inaccuracies in some cancer treatment research.
108. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
109. New Study Tells Researchers How Cancer Spreads
110. Researchers uncover reasons for patients’ adverse reactions to Cetuximab.
111. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
112. Synthetic Molecules May Help Battle Cancer
113. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
114. Exercise Shown to Fend Off Fatigue Caused by Cancer
115. Nanoparticles Could Deliver Cancer Drugs
116. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
117. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
118. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
119. “Bacteria Therapy” Shows Promise in Initial Tests
120. New UCLA Machine May Kill Cancer Cells
121. Study raises doubts about some DNA-based drugs
122. Disease-Causing Bugs May Help Treat Cancer
123. New Cancer Vaccine Approved for Limited Use in Russia
124. New Therapy Targets Hepatitis C
125. Innovative New Cancer Treatment Idea Earns $1 Million Prize
126. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
127. Nanoparticles Help Advance Anticancer siRNA Therapy
128. Research at MIT Shows microRNA’s Protective Role
129. Patients See Benefit From Self Reporting Symptoms Online
130. Cancer drugs from genetically modified chicken eggs
131. Researchers attempting to figure out how cancer grows
132. Antifolates – Chemotherapy drugs
133. Dopamine for cancer treatment
134. Concerns about anemia medications for cancer patients
135. Researchers Developing New Ways of Detecting Cancer
136. Recentin Study Ends
137. Phase II Study of Sutent ® Results Out
138. Terminally Ill Cancer Patients Given Hope in UK
139. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
140. PET Found to be effective in the Evaluation of Cancer Treatment
141. One-tird of cancer patients experience chronic fatigue after treatment
142. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
143. New DNA Discovery Changes the Way Doctors Look at Cancer.
144. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
145. Mouse Model For Mesothelioma Reproduces Human Disease
146. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
147. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
148. Remembering a researcher’s legacy on asbestos research
149. PET proves effective in evaluating cancer treatment
150. Trial on experimental antifolate PDX (Pralatrexate)
151. American College of Physicians releases guidelines for end-of-life care
152. Web-based system helps doctors track outpatients’ chemotherapy toxicity
153. NICE Gives Final Approval for Alimta
154. Par Pharmaceuticals licenses Onconase
155. Thalidomide and Alimta to be Combined in New Clinical Trial
156. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
157. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
158. Boysenberries might impede mesothelioma
159. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
160. New Mesothelioma Research Center to Open in Sydney
161. Virotherapy to Treat Mesothelioma
162. MIT researchers’ “nanocell” delivers a toxic double whammy to tumors
163. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
164. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
165. Researchers Identify Intracellular Pathway of Alfacell’s Onconase
166. New Study Heralds Shortened Timeline for Anticancer Drug Development
167. Talcum Powder Stunts Tumor Growth
168. Soluble mesothelin in effusions a strong indicator of mesothelioma
169. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
170. New Technology For Cancer Screening Listens For The Signs Of Cancer
171. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
172. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
173. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
174. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
175. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
176. Study shows Mesomark effective for monitoring Mesothelioma
177. FDA Grants Orphan Drug status to Onconase for Mesothelioma
178. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
179. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
180. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
181. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
182. Zolinza becomes first approved HDAC inhibitor
183. Alimta Researchers Recognized As Heroes Of Chemistry
184. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
185. FDA tells Eli Lilly that their Alimta brochure is misleading
186. News about onocology product candidate SS1P (renamed CAT-5001)
187. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
188. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
189. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
190. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
191. Scientist Reveals His Hopes for Better Tumour Treatment
192. Alfacell Drug Trial Ahead of Schedule
193. Alfacell Forms New Thoracic Cancer Advisory Board
194. Update on Onconase Clinical Program
195. Promising Research in Early Detection of Mesothelioma
196. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
197. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
198. Gene Drug Gives Mesothelioma Patient Second Chance
199. Novel therapies for pleural mesothelioma
200. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)